clinical trial · NCT07128628
A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye Disease
Dry Eye DiseaseLifitegrast/Perfluorohexyloctane Fixed Dose CombinationLifitegrastPerfluorohexyloctaneVehicleVehicleVehicle
brief summary
A 4-Week, Randomized, Double-Masked, Parallel-Group, Active-Controlled, Multicenter Study Evaluating Lifitegrast/Perfluorohexyloctane Fixed-Dose Combination Administered Twice Daily on Signs and Symptoms of Dry Eye Disease
started
Oct 24, 2025
primary completion
Nov 1, 2026
completion
Nov 1, 2026
last updated
Mar 13, 2026
official title
A 4-Week, Randomized, Double-Masked, Parallel-Group, Active-Controlled, Multicenter Study Evaluating Lifitegrast/Perfluorohexyloctane Fixed-Dose Combination Administered Twice Daily on Signs and Symptoms of Dry Eye Disease
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol